In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome (PCOS and ivf)
IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Adana, Turkey, 01120
- Bulent Haydardedeoglu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PCOS women undergoing ICSI cycles
- All women will be administered 150 IU rec FSH
Exclusion Criteria:
- Women having other endocrinopathies
- women older than 35
- third IVF/ICSI cycles
- previous and current use of metformin
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: GnRH Agonist
oral contraceptive pill and GnRH Agonist IVF/ICSI cycle
|
150 IU FSH dose and OCP plus GnRH Agonist (long luteal) IVF/ICSI cycle and 150 IU FSH dose and OCP plus GnRH Antagonist (Fixed protocol) IVF/ICSI Cycle
|
|
ACTIVE_COMPARATOR: GnRH Agonist Arm
Oral contraceptive pill and day 21 GnRH agonist began, Day 3 of menstruation 150 IU FSH will be started.
If 3 or more follicle reach >17 mm hCG will be administered.
|
150 IU FSH dose and OCP plus GnRH Agonist (long luteal) IVF/ICSI cycle and 150 IU FSH dose and OCP plus GnRH Antagonist (Fixed protocol) IVF/ICSI Cycle
GnRH Antagonist cycle; 150 IU FSH and sixth day Antagonist will be administered
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ongoing pregnancy rates
Time Frame: March 2009 to June 2011
|
Ongoing pregnancy rates measured in OCP plus GnRH Agonist and OCP plus GnRH Antagonist cycles in women with PCOS
|
March 2009 to June 2011
|
|
clinical pregnancy rate
Time Frame: from march 2009 to july 2011
|
To evaluate the clinical pregnancy rates of both study arms
|
from march 2009 to july 2011
|
|
Total gonadotropin use
Time Frame: From march 2009 to June 2011
|
Total gonadotropin use of both study arms
|
From march 2009 to June 2011
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
OHSS rates
Time Frame: from march 2009 to july 2011
|
OHSS rates in both study groups
|
from march 2009 to july 2011
|
|
Total ongoing pregnancy rate
Time Frame: from march 2009 to june 2011
|
Total ongoing pregnacy rates of per protocol group including freezing-thawing embryo transfer cycles.
|
from march 2009 to june 2011
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Bulent Haydardedeoglu, M.D., Baskent University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BH532008
- KA04/104 (OTHER: Baskent University KA04/104)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.